DRDO Developed Anti-Covid Drug Help To Reduces Supplemental Oxygen Dependence

0
108

COVID the deadly virus created dread across the country in the middle of that a relief for the nation. Yes, A drug to treat coronavirus patients, developed by the DRDO (Defence Research and Development Organisation), has been approved for emergency use by the country’s top drug controller as India battles the second wave of the pandemic that is killing thousands every day. As per the media reports, the drug comes in powder form in a sachet and is taken orally by dissolving it in water. A DRDO lab and Hyderabad-based Dr. Reddy’s Laboratories developed the anti-Covid therapeutic application of the drug 2-deoxy-D-glucose (2-DG) and Drugs Controller General of India (DCGI) cleared the drug after clinical trial results showed that a molecule present in the drug helps in faster recovery of hospitalized patients and also reduces supplemental oxygen dependence.

News By Priti

LEAVE A REPLY

Please enter your comment!
Please enter your name here